Cyber Swan Sale

50% Off Elite

Days

Hours

Mins

Sec

Get our most powerful screeners, new charting tools, and the fastest ad-free experience at our best price ever. One last chance.

Open in Screener

ISRG

Intuitive Surgical Inc

Dec 01 • 04:00PM ET

567.37

-6.11 -1.07 %

Healthcare • Medical Instruments & Supplies • USA • NASD

Peers: MDT SYK ABT JNJ BSX EW ZBH GMED TMDX

| Held by: VTI VOO QQQ IVV SPY VUG XLV IWF QQQM IHI

Index	NDX, S&P 500	P/E	75.10	EPS (ttm)	7.55	Insider Own	0.62%	Shs Outstand	354.90M	Perf Week	1.03%
Market Cap	201.13B	Forward P/E	58.55	EPS next Y	9.69	Insider Trans	-5.68%	Shs Float	352.31M	Perf Month	7.05%
Enterprise Value	196.33B	PEG	5.02	EPS next Q	2.25	Inst Own	85.71%	Short Float	2.12%	Perf Quarter	20.96%
Income	2.75B	P/S	20.92	EPS this Y	17.89%	Inst Trans	-1.75%	Short Ratio	3.08	Perf Half Y	2.54%
Sales	9.61B	P/B	11.89	EPS next Y	11.98%	ROA	14.81%	Short Interest	7.45M	Perf YTD	8.70%
Book/sh	47.70	P/C	40.97	EPS next 5Y	14.95%	ROE	16.90%	52W High	616.00 -7.89%	Perf Year	4.66%
Cash/sh	13.85	P/FCF	88.55	EPS past 3/5Y	11.25% 10.77%	ROIC	16.23%	52W Low	425.00 33.50%	Perf 3Y	114.55%
Dividend Est.	-	EV/EBITDA	57.80	Sales past 3/5Y	13.51% 13.27%	Gross Margin	66.37%	Volatility	1.80% 2.45%	Perf 5Y	136.72%
Dividend TTM	-	EV/Sales	20.43	EPS Y/Y TTM	21.37%	Oper. Margin	29.30%	ATR (14)	13.67	Perf 10Y	888.51%
Dividend Ex-Date	-	Quick Ratio	3.74	Sales Y/Y TTM	22.18%	Profit Margin	28.58%	RSI (14)	60.37	Recom	2.00
Dividend Gr. 3/5Y	- -	Current Ratio	4.73	EPS Q/Q	24.96%	SMA20	1.23%	Beta	1.67	Target Price	604.00
Payout	0.00%	Debt/Eq	0.00	Sales Q/Q	22.91%	SMA50	12.17%	Rel Volume	0.45	Prev Close	573.48
Employees	15638	LT Debt/Eq	0.00	Earnings	Oct 21 AMC	SMA200	11.39%	Avg Volume	2.42M	Price	567.37
IPO	Jun 13, 2000	Option/Short	Yes / Yes	EPS/Sales Surpr.	20.31% 4.10%	Trades		Volume	1,206,486	Change	-1.07%

Date	Action	Analyst	Rating Change	Price Target Change
Jul-23-25	Downgrade	Erste Group	Buy → Hold
Jun-09-25	Downgrade	Deutsche Bank	Hold → Sell	$440
Jun-05-25	Upgrade	Erste Group	Hold → Buy
Dec-02-24	Upgrade	Morgan Stanley	Equal-Weight → Overweight	$522 → $650
Aug-02-24	Upgrade	Redburn Atlantic	Neutral → Buy	$380 → $510
Jul-10-24	Reiterated	Citigroup	Buy	$462 → $512
May-30-24	Initiated	Goldman	Buy	$500
Nov-17-23	Initiated	HSBC Securities	Buy	$318
Jul-19-23	Initiated	Robert W. Baird	Outperform	$377
Apr-19-23	Reiterated	Wells Fargo	Overweight	$289 → $310
Apr-19-23	Reiterated	Truist	Buy	$300 → $325
Apr-19-23	Reiterated	Stifel	Buy	$285 → $315
Apr-19-23	Reiterated	RBC Capital Mkts	Outperform	$305 → $309
Apr-19-23	Reiterated	Raymond James	Outperform	$270 → $323
Apr-19-23	Reiterated	Morgan Stanley	Equal-Weight	$265 → $285
Apr-19-23	Reiterated	JP Morgan	Overweight	$250 → $335
Apr-19-23	Reiterated	Evercore ISI	In-line	$240 → $270
Apr-19-23	Reiterated	Citigroup	Buy	$305 → $317
Apr-19-23	Reiterated	BTIG Research	Buy	$284 → $313
Apr-19-23	Reiterated	BofA Securities	Buy	$300 → $315

Show Previous Ratings

Dec-01-25 11:00PM	The Pitfalls of Selling Stocks (and How to Avoid Them) (Motley Fool)
05:50PM	Here's Why Intuitive Surgical, Inc. (ISRG) Fell More Than Broader Market (Zacks)
05:12PM	Stocks To Watch As Google Drives Rattled But Rebounding Market (Investor's Business Daily)
11:47AM	GE HealthCare Unveils Next-Gen SIGNA MRI Systems to Elevate Efficiency (Zacks)
09:00AM	Intuitive Surgical, Inc. (ISRG) is Attracting Investor Attention: Here is What You Should Know (Zacks)
04:00AM	Loading…
04:00AM	Building a better robot: How Virtual Incision plans to challenge Intuitive (MedTech Dive)
Nov-30-25 06:30AM	3 Stocks to Buy and Hold: the Long-Term Play for Your Portfolio (Motley Fool)
Nov-29-25 05:17AM	Is Intuitive Surgical's Dominance Safe? 10 Years of Healthcare Upside (Motley Fool)
Nov-28-25 12:44PM	Here's Why You Should Retain Glaukos Stock in Your Portfolio (Zacks)
Nov-27-25 11:30AM	Why Is IQVIA (IQV) Up 6.4% Since Last Earnings Report? (Zacks)
09:13AM	Is Intuitive Surgical Stock Underperforming the Nasdaq? (Barchart)
Nov-26-25 01:00PM	EHC Expands in Tennessee Via New JV Facility With Vanderbilt Health (Zacks)
07:32AM	From Hospitals to ASCs: Will Refurbished Xi Systems Broaden ISRG's Reach? (Zacks)
Nov-24-25 11:09AM	GE HealthCare to Acquire Intelerad for $2.3B to Boost Cloud Imaging (Zacks)
09:00AM	Looking for Medical Stocks? The Zacks Rank Can Help You Find Winners (Zacks)
08:21AM	Loading…
08:21AM	ISRG vs. MDT: A High-Tech Robotics Faceoff in the Race for Leadership (Zacks)
07:53AM	Should You Hold Quest Diagnostics Stock in Your Portfolio for Now? (Zacks)
05:44AM	New Strong Buy Stocks for Nov. 24: SHIP, MD, and More (Zacks)
Nov-23-25 04:18PM	What Are the Best Healthcare Stocks to Buy Now? I Think It's Intuitive Surgical (ISRG) -- or, to Play It Safer, Medtronic (MDT) (Motley Fool)
04:10AM	2 Healthcare Stocks for Beginner Investors With a 10-Year Time Horizon (Motley Fool)
Nov-21-25 11:30AM	Why Is Thermo Fisher (TMO) Up 0.2% Since Last Earnings Report? (Zacks)
10:53AM	Veeva Systems Stock Down Despite Q3 Earnings & Revenues Top Estimates (Zacks)
10:50AM	Reasons to Hold AngioDynamics Stock in Your Portfolio for Now (Zacks)
08:11AM	LH Shares Gain Following Publication of New Plasma Detect MRD Data (Zacks)
Nov-20-25 02:36PM	Bruker Stock Earns Relative Strength Rating Upgrade (Investor's Business Daily)
11:30AM	Why Is Intuitive Surgical (ISRG) Up 7.1% Since Last Earnings Report? (Zacks)
09:35AM	Intuitive Surgical, Inc. (ISRG) Recently Broke Out Above the 20-Day Moving Average (Zacks)
09:34AM	Reasons to Add HealthEquity Stock to Your Portfolio for Now (Zacks)
08:30AM	If You Invested $1000 in Intuitive Surgical, Inc. a Decade Ago, This is How Much It'd Be Worth Now (Zacks)
07:43AM	The Zacks Analyst Blog Highlights Walmart, Intuitive Surgical, Lam Research and BV Financial (Zacks)
03:57AM	Loading…
03:57AM	Where Will Intuitive Surgical Stock Be in 10 Years? (Motley Fool)
Nov-19-25 04:13PM	Top Stock Reports for Walmart, Intuitive Surgical & Lam Research (Zacks)
08:02AM	Will Ion Platform's 52% Growth Make It ISRG's Next Growth Engine? (Zacks)
06:18AM	Intuitive Surgical (ISRG) Fell Despite Reporting Strong Results (Insider Monkey)
Nov-18-25 11:39AM	BFLY Stock Down Despite Launching Compass AI to Drive POCUS Programs (Zacks)
09:00AM	Intuitive Surgical, Inc. (ISRG) Is a Trending Stock: Facts to Know Before Betting on It (Zacks)
07:13AM	Intuitive Surgical Stock: Is Wall Street Bullish or Bearish? (Barchart)
Nov-17-25 12:39PM	Ecolab Launches Integrated Cooling Platform to Support AI Data Centers (Zacks)
Nov-16-25 04:50AM	Robotic Surgery Will Explode: Buy This Healthcare Stock Before Its 50% Run. (Motley Fool)
Nov-14-25 07:00PM	9 Robotics Stocks to Buy Before the Automation Wave Peaks (Motley Fool)
01:23PM	Is Intuitive Surgical's (ISRG) Valuation Limiting Further Upside After Earnings? (Insider Monkey)
10:29AM	Intuitive Surgical Stock Is Up 31% Since October Lows After Powerful Earnings Turnaround (Investor's Business Daily)
08:20AM	Is It Time to Dump Your Shares of Intuitive Surgical? (Motley Fool)
08:02AM	HealthEquity Rolls Out Agentic AI to Elevate Member Support Experience (Zacks)
Nov-13-25 10:39AM	Cornerstone raises $200M to commercialize surgical robot (MedTech Dive)
08:52AM	Is Force Feedback the Next Big Catalyst for ISRG's da Vinci Sales? (Zacks)
08:46AM	Insulet Stock Up Post Q3 Earnings & Revenue Beat, Margins Expand (Zacks)
05:04AM	2 Healthcare Stocks for Beginner Investors With a 40-Year Time Horizon (Motley Fool)
Nov-12-25 09:00PM	The Motley Fool Analysts Andy Cross, Emily Flippen, and Jason Moser on How Tariffs Are Impacting Intuitive Surgical's Profits Right Now (Motley Fool)
06:00AM	Izzy Englander and Cathie Wood Agree: This Growth Stock Is a Buy (Motley Fool)
Nov-11-25 09:45AM	Intuitive Surgical Is the Robotic-Assisted Surgery Leader, but Medtronic Is Making Moves. Here's What Investors Need to Know. (Motley Fool)
08:29AM	Should You Hold Intuitive Surgical (ISRG)? (Insider Monkey)
07:55AM	Penumbra Stock Up Post Q3 Earnings & Revenue Beat, Margins Expand (Zacks)
Nov-10-25 06:21PM	Intel Appoints Dr. Craig H. Barratt to Board of Directors (Business Wire)
07:50AM	What's Behind Boston Scientific's Optimism for Urology Growth? (Zacks)
07:47AM	ISRG Stock Gains More than 28% in a Month: Should You Buy, Hold or Sell? (Zacks)
Nov-07-25 09:00AM	Investors Heavily Search Intuitive Surgical, Inc. (ISRG): Here is What You Need to Know (Zacks)
Nov-05-25 09:22AM	CRL's Q3 Earnings Top Estimates, Revenues Decline Y/Y, Stock Falls (Zacks)
Nov-04-25 11:00PM	2 Reasons to Watch ISRG and 1 to Stay Cautious (StockStory)
01:07PM	IBD Stock Of The Day: Why Robotics Giant Intuitive Surgical Has Surged (Investor's Business Daily)
11:40AM	ALC or ISRG: Which Is the Better Value Stock Right Now? (Zacks)
08:07AM	HOLX Stock Up on Q4 Earnings & Revenue Beat, Operating Margin Expands (Zacks)
07:08AM	Intuitive Surgical (ISRG) Fell Due to Investor Concerns (Insider Monkey)
06:11AM	How Intuitive Surgical Stock Gained 19.5% Last Month (Motley Fool)
Nov-03-25 05:18PM	Top Stock Picks for Week of November 3, 2025 (Zacks)
12:45PM	$134M in Insider Moves: What It Might Mean for KMI, ISRG and QS (MarketBeat)
08:28AM	2 Healthcare Stocks for Individual Investors With a 30-Year Time Horizon (Motley Fool)
Nov-02-25 07:23PM	3 Brilliant Growth Stocks to Buy Now and Hold for the Long Term (Motley Fool)
Oct-31-25 02:01PM	Merit Medical Q3 Earnings & Revenues Beat Estimate, Margins Expand (Zacks)
11:05AM	BFLY's Q3 Earnings Miss Estimates, Revenues Surpass, Stock Climbs (Zacks)
09:30AM	Prediction: These 2 Magnificent S&P 500 Growth Stocks Will Crush the Market Over the Next 5 Years (Motley Fool)
08:22AM	Resmed Stock Up on Q1 Earnings & Revenue Beat, Margins Expand (Zacks)
Oct-30-25 09:04AM	Bio-Rad's Q3 Earnings Miss Estimates, Revenues Surpass, Stock Falls (Zacks)
08:38AM	Looking to Diversify Out of the AI Trade? Buy Boston Scientific Stock. (Barrons.com)
Oct-29-25 09:00AM	CVS Stock Falls Despite Q3 Earnings & Revenue Beat, '25 EPS View Up (Zacks)
08:58AM	ISRG vs BSX: Comparing Q3 Earnings, Growth Strategies and Prospects (Zacks)
07:15AM	3 Robotics Stocks to Buy Right Now (Motley Fool)
06:30AM	Bull of the Day: Intuitive Surgical (ISRG) (Zacks)
04:36AM	Intuitive Surgical and Oklo have been highlighted as Zacks Bull and Bear of the Day (Zacks)
Oct-28-25 02:12PM	Universal Health's Q3 Earnings Top on Patient Volumes, Ups '25 EPS View (Zacks)
10:00AM	ISRG Rides on da Vinci 5 Momentum: Can This Growth Sustain? (Zacks)
09:18AM	Top 3 Stocks Powering Through Trump's Tariff Policies (MarketBeat)
01:33AM	Intuitive Surgical's Q3 Earnings Call: Our Top 5 Analyst Questions (StockStory)
Oct-27-25 10:45AM	3 Healthcare Stocks to Buy Hand Over Fist in October (Motley Fool)
10:00AM	Best Momentum Stock to Buy for Oct. 27th (Zacks)
09:30AM	Is Intuitive Surgical (ISRG) a Buy as Wall Street Analysts Look Optimistic? (Zacks)
09:00AM	Here is What to Know Beyond Why Intuitive Surgical, Inc. (ISRG) is a Trending Stock (Zacks)
08:40AM	Intuitive Surgical vs. Medtronic: Which Stock Is the Better Buy? (Motley Fool)
Oct-26-25 04:39AM	2 Brilliant Medical Device Stocks to Buy Now and Hold for the Long Term (Motley Fool)
Oct-25-25 12:44AM	Jim Cramer Highlights Intuitive Surgical Rally on Unexpected Procedure Growth (Insider Monkey)
Oct-24-25 03:40PM	"I Like That," Says Jim Cramer About Intuitive Surgical (ISRG) (Insider Monkey)
12:39PM	Why Intuitive Surgical Stock Zoomed 23% Higher This Week (Motley Fool)
10:52AM	Zacks Investment Ideas feature highlights: Intuitive Surgical's (Zacks)
04:16AM	This Robotics Stock Is a Far Better Investment Than Palantir (Motley Fool)
Oct-23-25 04:34PM	Earnings live: Intel stock surges, Ford rises after-hours, Deckers drops (Yahoo Finance)
04:29PM	Buy the Post-Earnings Surge in Intuitive Surgical (ISRG) Stock? (Zacks)
09:28AM	Company News for Oct 23, 2025 (Zacks)
08:09AM	Earnings live: Tesla stock falls after earnings miss, American Airlines climbs, IBM and Hasbro sink (Yahoo Finance)
04:20AM	1 Growth Stock Down 25% to Buy Right Now (Motley Fool)
03:43AM	Medtronic Is Diving Into the Robotic-Assisted Surgery Market. Can It Compete With the Industry Leader? (Motley Fool)

Intuitive Surgical, Inc. engages in the provision of robotic-assisted surgical solutions and invasive care through a comprehensive ecosystem of products and services. Its products include Da Vinci Surgical and Ion Endoluminal systems. The company was founded by Frederic H. Moll, John Gordon Freund, and Robert G. Younge in November 1995 and is headquartered in Sunnyvale, CA.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
GARY S GUTHART	Officer	Dec 01 '25	Proposed Sale	570.89	22,806	13,019,722		Dec 01 04:48 PM
MYRIAM CURET MCADAMS	Officer	Dec 01 '25	Proposed Sale	568.99	125	71,124		Dec 01 04:05 PM
Charlton Henry L	EVP & Chief Commercial and Mkt	Nov 12 '25	Option Exercise	229.95	9,000	2,069,552	10,688	Nov 13 01:55 PM
Charlton Henry L	EVP & Chief Commercial and Mkt	Nov 12 '25	Sale	580.00	13,731	7,963,980	3,056	Nov 13 01:55 PM
BARRATT CRAIG H	Director	Nov 12 '25	Option Exercise	71.32	750	53,492	750	Nov 13 01:46 PM
BARRATT CRAIG H	Director	Nov 12 '25	Sale	580.00	750	435,000	0	Nov 13 01:46 PM
HENRY CHARLTON	Officer	Nov 12 '25	Proposed Sale	580.00	13,731	7,963,980		Nov 12 04:04 PM
CRAIG H BARRATT	Director	Nov 12 '25	Proposed Sale	580.00	750	435,000		Nov 12 04:01 PM
Curet Myriam	EVP & Chief Medical Officer	Nov 10 '25	Option Exercise	229.39	105	24,086	105	Nov 12 02:12 PM
Curet Myriam	EVP & Chief Medical Officer	Nov 10 '25	Sale	560.00	105	58,800	0	Nov 12 02:12 PM
Miller Brian Edward	EVP & Chief Digital Officer	Nov 10 '25	Option Exercise	216.50	3,500	757,746	7,960	Nov 12 02:03 PM
Miller Brian Edward	EVP & Chief Digital Officer	Nov 10 '25	Sale	575.00	3,500	2,012,500	5,758	Nov 12 02:03 PM
BRIAN MILLER	Officer	Nov 10 '25	Proposed Sale	575.00	3,500	2,012,500		Nov 10 06:18 PM
MYRIAM CURET MCADAMS	Officer	Nov 10 '25	Proposed Sale	560.00	105	58,800		Nov 10 04:01 PM
Widman Fredrik	VP Corporate Controller	Nov 05 '25	Option Exercise	75.65	2,067	156,368	2,381	Nov 06 02:17 PM
Widman Fredrik	VP Corporate Controller	Nov 05 '25	Sale	550.00	2,067	1,136,850	473	Nov 06 02:17 PM
FREDRIK WIDMAN	Officer	Nov 05 '25	Proposed Sale	550.00	2,067	1,136,850		Nov 05 04:36 PM
Curet Myriam	EVP & Chief Medical Officer	Oct 28 '25	Option Exercise	234.27	7,562	1,771,513	5,383	Oct 29 07:48 PM
Curet Myriam	EVP & Chief Medical Officer	Oct 29 '25	Option Exercise	208.90	125	26,112	125	Oct 29 07:48 PM
Curet Myriam	EVP & Chief Medical Officer	Oct 28 '25	Sale	548.43	7,562	4,147,193	353	Oct 29 07:48 PM
Curet Myriam	EVP & Chief Medical Officer	Oct 29 '25	Sale	543.00	125	67,875	0	Oct 29 07:48 PM
MYRIAM CURET MCADAMS	Officer	Oct 29 '25	Proposed Sale	543.00	125	67,875		Oct 29 04:06 PM
MYRIAM CURET MCADAMS	Officer	Oct 28 '25	Proposed Sale	548.43	7,562	4,147,192		Oct 28 04:09 PM
GUTHART GARY S	Executive Chair of the Board o	Oct 24 '25	Option Exercise	109.49	36,000	3,941,482	55,827	Oct 27 04:11 PM
GUTHART GARY S	Executive Chair of the Board o	Oct 24 '25	Sale	547.56	28,800	15,769,644	27,027	Oct 27 04:11 PM
GUTHART GARY S	Executive Chair of the Board o	Oct 24 '25	Sale	546.27	2,800	1,529,547	17,120	Oct 27 04:11 PM
BARRATT CRAIG H	Director	Oct 24 '25	Option Exercise	71.32	2,193	156,412	2,193	Oct 27 03:56 PM
BARRATT CRAIG H	Director	Oct 24 '25	Sale	548.01	2,193	1,201,786	0	Oct 27 03:56 PM
Rosa David J.	Chief Executive Officer (CEO)	Oct 24 '25	Option Exercise	79.64	27,000	2,150,221	258,756	Oct 27 03:36 PM
Rosa David J.	Chief Executive Officer (CEO)	Oct 24 '25	Sale	547.55	24,500	13,414,980	234,256	Oct 27 03:36 PM
GARY S GUTHART	Officer	Oct 24 '25	Proposed Sale	547.56	28,800	15,769,644		Oct 24 04:34 PM
DAVID ROSA	Officer	Oct 24 '25	Proposed Sale	547.55	24,500	13,414,977		Oct 24 04:29 PM
CRAIG H BARRATT	Director	Oct 24 '25	Proposed Sale	548.01	2,193	1,201,786		Oct 24 04:05 PM
LOEB GARY	EVP & Chief Legal and Complian	Oct 10 '25	Option Exercise	0.00	2,612	0	4,857	Oct 10 02:25 PM
Ladd Amy L	Director	Sep 03 '25	Sale	470.11	336	157,957	1,074	Sep 04 06:55 PM
Ladd Amy L	Director	Sep 04 '25	Sale	440.69	335	147,631	739	Sep 04 06:55 PM
AMY L LADD	Director	Sep 04 '25	Proposed Sale	440.69	335	147,631		Sep 04 04:05 PM
AMY L LADD	Director	Sep 03 '25	Proposed Sale	470.11	336	157,957		Sep 03 04:01 PM
GUTHART GARY S	Executive Chair of the Board o	Aug 29 '25	Option Exercise	79.64	36,000	2,866,961	49,187	Sep 02 04:16 PM
GUTHART GARY S	Executive Chair of the Board o	Aug 29 '25	Sale	472.49	29,360	13,872,227	19,827	Sep 02 04:16 PM
GARY S GUTHART	Officer	Aug 29 '25	Proposed Sale	472.49	29,360	13,872,227		Aug 29 04:35 PM
GUTHART GARY S	Executive Chair of the Board o	Jul 28 '25	Option Exercise	59.46	7,893	469,335	21,080	Jul 29 01:02 PM
GUTHART GARY S	Executive Chair of the Board o	Jul 28 '25	Sale	498.64	7,893	3,935,756	13,187	Jul 29 01:02 PM
GUTHART GARY S	Executive Chair of the Board o	Jul 28 '25	Sale	495.24	2,800	1,386,663	18,520	Jul 29 01:02 PM
GARY S GUTHART	Officer	Jul 28 '25	Proposed Sale	498.64	7,893	3,935,755		Jul 28 04:25 PM
GUTHART GARY S	Officer	Jul 28 '25	Proposed Sale	495.24	5,600	2,773,344		Jul 28 10:17 AM
Curet Myriam	EVP & Chief Medical Officer	Jul 25 '25	Option Exercise	242.34	4,500	1,090,515	4,853	Jul 25 06:50 PM
Curet Myriam	EVP & Chief Medical Officer	Jul 25 '25	Sale	492.48	4,500	2,216,160	353	Jul 25 06:50 PM
MYRIAM CURET MCADAMS	Officer	Jul 25 '25	Proposed Sale	492.48	4,500	2,216,160		Jul 25 04:10 PM
ROBERT DESANTIS	Officer	Jun 10 '25	Proposed Sale	525.81	240	126,194		Jun 10 04:01 PM
Rosa David J.	President	Jun 10 '25	Option Exercise	0.00	1,358	0	232,430	Jun 10 12:36 PM
Brosius Mark	SVP & Chief Mfg and Supply Cha	Jun 06 '25	Sale	563.11	216	121,632	907	Jun 06 04:20 PM
Brosius Mark	SVP & Chief Mfg and Supply Cha	Jun 05 '25	Sale	560.70	215	120,551	1,123	Jun 06 04:20 PM
MARK BROSIUS	Officer	Jun 06 '25	Proposed Sale	563.11	216	121,632		Jun 06 04:05 PM
MARK BROSIUS	Officer	Jun 05 '25	Proposed Sale	560.70	215	120,550		Jun 05 04:48 PM
Brosius Mark	SVP & Chief Mfg and Supply Cha	Jun 04 '25	Sale	552.07	215	118,695	1,338	Jun 04 06:44 PM
Brosius Mark	SVP & Chief Mfg and Supply Cha	Jun 03 '25	Sale	550.68	215	118,396	1,553	Jun 04 06:44 PM
Brosius Mark	SVP & Chief Mfg and Supply Cha	Jun 02 '25	Sale	549.06	215	118,048	1,768	Jun 04 06:44 PM
MARK BROSIUS	Officer	Jun 04 '25	Proposed Sale	552.07	215	118,695		Jun 04 04:01 PM
MARK BROSIUS	Officer	Jun 03 '25	Proposed Sale	550.68	215	118,396		Jun 03 04:36 PM
MARK BROSIUS	Officer	Jun 02 '25	Proposed Sale	549.06	215	118,048		Jun 02 04:04 PM
ROBERT DESANTIS	Officer	May 29 '25	Proposed Sale	556.47	188	104,616		May 29 04:01 PM
ROBERT DESANTIS	Officer	May 28 '25	Proposed Sale	550.51	188	103,496		May 28 04:10 PM
Brosius Mark	SVP & Chief Mfg and Supply Cha	May 15 '25	Sale	560.00	22	12,320	2,003	May 16 06:58 PM
Brosius Mark	SVP & Chief Mfg and Supply Cha	May 16 '25	Sale	563.81	20	11,276	1,983	May 16 06:58 PM
MARK BROSIUS	Officer	May 16 '25	Proposed Sale	563.81	20	11,276		May 16 04:05 PM
MARK BROSIUS	Officer	May 15 '25	Proposed Sale	560.00	22	12,320		May 15 04:02 PM
Brosius Mark	SVP & Chief Mfg and Supply Cha	May 14 '25	Sale	563.00	22	12,386	2,025	May 14 06:18 PM
Brosius Mark	SVP & Chief Mfg and Supply Cha	May 13 '25	Sale	561.67	22	12,357	2,047	May 14 06:18 PM
Brosius Mark	SVP & Chief Mfg and Supply Cha	May 12 '25	Sale	551.97	22	12,143	2,069	May 14 06:18 PM
MARK BROSIUS	Officer	May 14 '25	Proposed Sale	563.00	22	12,386		May 14 04:05 PM
MARK BROSIUS	Officer	May 13 '25	Proposed Sale	561.67	22	12,357		May 13 04:02 PM
MARK BROSIUS	Officer	May 12 '25	Proposed Sale	551.97	22	12,143		May 12 04:04 PM
ROBERT DESANTIS	Officer	May 12 '25	Proposed Sale	551.97	433	239,003		May 12 04:03 PM
Samath Jamie	See Remarks	May 02 '25	Option Exercise	259.91	915	237,822	8,077	May 05 04:43 PM
Samath Jamie	See Remarks	May 02 '25	Sale	527.95	915	483,074	7,162	May 05 04:43 PM
JAMIE E SAMATH	Officer	May 02 '25	Proposed Sale	527.95	915	483,074		May 02 04:06 PM
NACHTSHEIM JAMI K	Director	May 01 '25	Option Exercise	90.49	2,400	217,187	8,771	May 01 09:12 PM
NACHTSHEIM JAMI K	Director	May 01 '25	Sale	520.00	2,400	1,248,000	6,371	May 01 09:12 PM
Ladd Amy L	Director	Apr 30 '25	Option Exercise	229.31	8,776	2,012,405	3,708	May 01 08:24 PM
Ladd Amy L	Director	Apr 30 '25	Sale	505.55	8,776	4,436,671	1,410	May 01 08:24 PM
JAMI NACHTSHEIM	Director	May 01 '25	Proposed Sale	520.00	2,400	1,248,000		May 01 04:03 PM
AMY L LADD	Director	Apr 30 '25	Proposed Sale	505.55	8,776	4,436,671		Apr 30 04:01 PM
DeSantis Robert	EVP & Chief Strategy & Corp Op	Apr 25 '25	Option Exercise	256.37	614	157,408	5,412	Apr 29 06:07 PM
DeSantis Robert	EVP & Chief Strategy & Corp Op	Apr 28 '25	Option Exercise	290.33	188	54,582	5,412	Apr 29 06:07 PM
DeSantis Robert	EVP & Chief Strategy & Corp Op	Apr 29 '25	Option Exercise	208.90	188	39,273	5,412	Apr 29 06:07 PM
DeSantis Robert	EVP & Chief Strategy & Corp Op	Apr 25 '25	Sale	513.18	614	315,093	5,224	Apr 29 06:07 PM
DeSantis Robert	EVP & Chief Strategy & Corp Op	Apr 28 '25	Sale	515.91	188	96,991	5,224	Apr 29 06:07 PM
DeSantis Robert	EVP & Chief Strategy & Corp Op	Apr 29 '25	Sale	512.90	188	96,425	5,224	Apr 29 06:07 PM
ROBERT DESANTIS	Officer	Apr 29 '25	Proposed Sale	512.90	188	96,425		Apr 29 04:01 PM
ROBERT DESANTIS	Officer	Apr 28 '25	Proposed Sale	515.91	188	96,991		Apr 28 04:01 PM
Curet Myriam	EVP & Chief Medical Officer	Apr 25 '25	Option Exercise	242.34	4,000	969,347	4,353	Apr 28 02:04 PM
Curet Myriam	EVP & Chief Medical Officer	Apr 25 '25	Sale	513.18	4,000	2,052,720	353	Apr 28 02:04 PM
LOEB GARY	EVP & Chief Legal and Complian	Apr 25 '25	Sale	513.18	1,700	872,406	2,245	Apr 25 07:37 PM
NACHTSHEIM JAMI K	Director	Apr 25 '25	Option Exercise	0.00	739	0	6,371	Apr 25 04:33 PM
CHEW LEWIS	Director	Apr 25 '25	Option Exercise	0.00	739	0	783	Apr 25 04:20 PM
Johnson Amal M	Director	Apr 25 '25	Option Exercise	0.00	739	0	13,014	Apr 25 04:09 PM
MYRIAM CURET MCADAMS	Officer	Apr 25 '25	Proposed Sale	513.18	4,000	2,052,720		Apr 25 04:02 PM
ROBERT DESANTIS	Officer	Apr 25 '25	Proposed Sale	513.18	614	315,093		Apr 25 04:01 PM
GARY LOEB	Officer	Apr 25 '25	Proposed Sale	513.18	1,700	872,406		Apr 25 04:01 PM

Open in Screener

CAMP

CAMP4 Therapeutics Corp

Dec 01 • 04:00PM ET

3.24

-0.56 -14.74 %

Healthcare • Biotechnology • USA • NASD

CAMP CAMP4 Therapeutics Corp daily Stock Chart

Held by: VTI VXF IWC

Index	-	P/E	-	EPS (ttm)	-2.45	Insider Own	61.11%	Shs Outstand	46.88M	Perf Week	11.72%
Market Cap	151.89M	Forward P/E	-	EPS next Y	-1.00	Insider Trans	24.24%	Shs Float	18.23M	Perf Month	-19.60%
Enterprise Value	82.99M	PEG	-	EPS next Q	-0.34	Inst Own	34.39%	Short Float	2.34%	Perf Quarter	107.69%
Income	-53.40M	P/S	39.97	EPS this Y	82.88%	Inst Trans	19.46%	Short Ratio	0.54	Perf Half Y	62.00%
Sales	3.80M	P/B	2.59	EPS next Y	47.08%	ROA	-99.11%	Short Interest	0.43M	Perf YTD	-37.93%
Book/sh	1.25	P/C	2.02	EPS next 5Y	57.24%	ROE	-172.70%	52W High	10.80 -70.00%	Perf Year	-34.41%
Cash/sh	1.61	P/FCF	-	EPS past 3/5Y	-6.52% -	ROIC	-86.46%	52W Low	1.30 148.28%	Perf 3Y	-
Dividend Est.	-	EV/EBITDA	-	Sales past 3/5Y	- -	Gross Margin	55.68%	Volatility	13.56% 13.70%	Perf 5Y	-
Dividend TTM	-	EV/Sales	21.84	EPS Y/Y TTM	-	Oper. Margin	-1402.39%	ATR (14)	0.46	Perf 10Y	-
Dividend Ex-Date	-	Quick Ratio	9.83	Sales Y/Y TTM	-	Profit Margin	-1404.47%	RSI (14)	43.10	Recom	1.33
Dividend Gr. 3/5Y	- -	Current Ratio	9.83	EPS Q/Q	17.22%	SMA20	-15.90%	Beta	1.44	Target Price	10.39
Payout	-	Debt/Eq	0.11	Sales Q/Q	-	SMA50	-8.67%	Rel Volume	0.10	Prev Close	3.80
Employees	55	LT Debt/Eq	0.05	Earnings	Nov 06 AMC	SMA200	17.74%	Avg Volume	793.88K	Price	3.24
IPO	Oct 11, 2024	Option/Short	No / Yes	EPS/Sales Surpr.	-14.99% 83.66%	Trades		Volume	81,953	Change	-14.74%

Date	Action	Analyst	Rating Change	Price Target Change
Oct-02-25	Initiated	Cantor Fitzgerald	Overweight	$7
Sep-16-25	Downgrade	JP Morgan	Overweight → Neutral
May-27-25	Initiated	Wedbush	Outperform	$8
Nov-05-24	Initiated	William Blair	Outperform
Nov-05-24	Initiated	Piper Sandler	Overweight	$18
Nov-05-24	Initiated	JP Morgan	Overweight	$23

Nov-14-25 04:05PM	CAMP4 Therapeutics Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) (GlobeNewswire)
Nov-06-25 04:05PM	CAMP4 Reports Third Quarter 2025 Financial Results and Corporate Highlights (GlobeNewswire) +6.97%
Oct-14-25 02:09PM	3 Healthcare Companies Insiders Are Buying (MarketBeat) -6.63%
Oct-01-25 08:00AM	CAMP4 Therapeutics Initiates GLP Toxicology Studies for CMP-SYNGAP-01 (GlobeNewswire)
Sep-25-25 12:00PM	CAMP4 Therapeutics Corporation (CAMP) Upgraded to Buy: Here's What You Should Know (Zacks) +7.53%
09:40AM	Loading…
Sep-17-25 09:40AM	Apple initiated, Hershey upgraded: Wall Streets top analyst calls (TipRanks) -6.50%
Sep-16-25 09:35AM	Apple initiated, Hershey upgraded: Wall Street's top analyst calls (The Fly)
Sep-10-25 07:00AM	CAMP4 Announces an Oversubscribed Private Placement of up to $100 Million to Advance First-in-Class Treatment for SYNGAP1-Related Disorders (GlobeNewswire) +40.20%
Aug-14-25 04:05PM	CAMP4 Reports Second Quarter 2025 Financial Results and Corporate Highlights (GlobeNewswire) +6.16% +7.74%
Jun-30-25 08:00AM	Sequans Appoints Jason W. Cohenour to Board of Directors (Newsfile)
May-16-25 06:00AM	CAMP4 Presents Translational Data from SYNGAP1-Related Disorders Program Showcasing Increased Protein in Non-Human Primates and Reviews Preclinical and Detailed Single Ascending Dose Safety Data from Urea Cycle Disorders Program at the 28th American Society of Gene and Cell Therapy Annual Meeting (GlobeNewswire) +9.52%
May-13-25 04:05PM	CAMP4 Reports First Quarter 2025 Financial Results and Corporate Highlights (GlobeNewswire) -7.92%
Apr-28-25 04:30PM	CAMP4 to Present New Preclinical Data from its Urea Cycle Disorders and SYNGAP1-Related Disorders Programs at the 28th American Society of Gene and Cell Therapy Annual Meeting (GlobeNewswire) -10.00% -5.15%
Apr-05-25 11:00AM	Markets Watch Out For Core CPI With Big Banks Set To Report Earnings (Seeking Alpha)
Mar-27-25 04:05PM	CAMP4 Reports Full Year 2024 Financial Results and Provides Corporate Update (GlobeNewswire) -10.16%
08:00AM	Loading…
Mar-18-25 08:00AM	CAMP4 Appoints Multiple Industry Veterans to its Board of Directors (GlobeNewswire)
Mar-04-25 05:24AM	CAMP4 Therapeutics Corporation (CAMP): Among Penny Stocks with Insider Buying in 2025 (Insider Monkey) -5.27%
Feb-06-25 08:00AM	CAMP4 to Participate in Upcoming Investor Conferences (GlobeNewswire) -6.95%
Jan-13-25 08:00AM	CAMP4 to Present at the 43rd Annual J.P. Morgan Healthcare Conference (GlobeNewswire)
Jan-07-25 04:05PM	CAMP4 Provides Corporate Updates and Highlights Key Upcoming Milestones (GlobeNewswire)
Dec-10-24 08:00AM	CAMP4 Appoints John Maraganore and Rachel Meyers as Strategic Advisors (GlobeNewswire) -8.08%
Dec-02-24 08:00AM	CAMP4 to Participate in the Piper Sandler 36th Annual Healthcare Conference (GlobeNewswire) +5.85%
Nov-21-24 04:05PM	CAMP4 Reports Third Quarter 2024 Financial Results (GlobeNewswire) +8.44% -6.40%
Oct-10-24 07:07PM	CAMP4 Announces Pricing of Initial Public Offering (GlobeNewswire)

CAMP4 Therapeutics Corp. operates as a biotechnology company which engages in the discovery of treatment options for patients. The company was founded by Richard A. Young and Leonard Zon in 2015 and is headquartered in Cambridge, MA.